{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:17Z","timestamp":1787003717549,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-67845-6","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T10:02:35Z","timestamp":1723197755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Factors associated with incomplete tuberculosis preventive treatment: a retrospective analysis of six-years programmatic data in Cambodia"],"prefix":"10.1038","volume":"14","author":[{"given":"Yom","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Eam","family":"Khun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"issue":"22","key":"67845_CR1","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1056\/NEJMra1405427","volume":"372","author":"H Getahun","year":"2015","unstructured":"Getahun, H., Matteelli, A., Chaisson, R. E. & Raviglione, M. Latent Mycobacterium tuberculosis infection. N. Engl. J. Med. 372(22), 2127\u20132135 (2015).","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"67845_CR2","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1016\/S2214-109X(14)70245-1","volume":"2","author":"PJ Dodd","year":"2014","unstructured":"Dodd, P. J., Gardiner, E., Coghlan, R. & Seddon, J. A. Burden of childhood tuberculosis in 22 high-burden countries: A mathematical modelling study. Lancet Glob. Health 2(8), e453\u2013e459 (2014).","journal-title":"Lancet Glob. Health"},{"key":"67845_CR3","unstructured":"World Health Organization. Implementing the end TB strategy: the essentials. Geneva: World Health Organization; 2015. Report No.: 9241509937."},{"key":"67845_CR4","volume-title":"Global tuberculosis report 2023","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Global tuberculosis report 2023 (World Health Organization, 2023)."},{"issue":"5","key":"67845_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.pulmoe.2020.04.004","volume":"28","author":"R De Aguiar","year":"2022","unstructured":"De Aguiar, R. et al. Factors associated with non-completion of latent tuberculosis infection treatment in Rio de Janeiro, Brazil: A non-matched case control study. Pulmonology. 28(5), 350\u2013357 (2022).","journal-title":"Pulmonology."},{"issue":"4","key":"67845_CR6","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10096-019-03765-y","volume":"39","author":"A Sent\u00eds","year":"2020","unstructured":"Sent\u00eds, A. et al. Failure to complete treatment for latent tuberculosis infection in Portugal, 2013\u20132017: Geographic-, sociodemographic-, and medical-associated factors. Eur. J. Clin. Microbiol. Infect. Dis. 39(4), 647\u2013656 (2020).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"2","key":"67845_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jiph.2013.11.001","volume":"7","author":"S-H Chang","year":"2014","unstructured":"Chang, S.-H., Eitzman, S. R., Nahid, P. & Finelli, M. L. U. Factors associated with failure to complete isoniazid therapy for latent tuberculosis infection in children and adolescents. J. infect. Public Health 7(2), 145\u2013152 (2014).","journal-title":"J. infect. Public Health"},{"issue":"6","key":"67845_CR8","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/phn.12798","volume":"37","author":"F Nguyen Truax","year":"2020","unstructured":"Nguyen Truax, F. et al. Non-completion of latent tuberculosis infection treatment among Vietnamese immigrants in Southern California: A retrospective study. Public Health Nurs. 37(6), 846\u2013853 (2020).","journal-title":"Public Health Nurs."},{"issue":"11","key":"67845_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jiac.2020.05.007","volume":"26","author":"Y Sugishita","year":"2020","unstructured":"Sugishita, Y., Goto, C., Sakamoto, T., Sugawara, T. & Ohkusa, Y. Risk factors affecting the failure to complete treatment for patients with latent tuberculosis infection in Tokyo Japan. J. Infect. Chemother. 26(11), 1129\u20131133 (2020).","journal-title":"J. Infect. Chemother."},{"key":"67845_CR10","unstructured":"World Health Organization. Tuberculosis profile: Cambodia: World Health Organization; 2022 [Available from: https:\/\/worldhealthorg.shinyapps.io\/tb_profiles\/?_inputs_&entity_type=%22country%22&lan=%22EN%22&iso2=%22KH%22"},{"issue":"10","key":"67845_CR11","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben, R. M. & Dodd, P. J. The global burden of latent tuberculosis infection: A re-estimation using mathematical modelling. PLoS Med. 13(10), e1002152 (2016).","journal-title":"PLoS Med."},{"key":"67845_CR12","unstructured":"The National Center for Tuberculosis and Leprosy Control. Programmatic Management of Latent TB Infection (LTBI): Standard Operating Procedures for LTBI Management and TB Preventative Therapy (TPT). Phnom Penh, Cambodia; (2020)."},{"key":"67845_CR13","unstructured":"National Center for Tuberculosis and Leprosy Control (CENAT). Programatic management of latent TB infection (LTBI): Standard operation procedure for LTBI management and TB preventive therapy (TPT). Phnom Penh, Cambodia; (2020)."},{"key":"67845_CR14","unstructured":"World Health Organization. WHO operational handbook on tuberculosis: module 1: prevention: tuberculosis preventive treatment. Genera: World Health Organization; 2020. Report No.: 9240002901."},{"issue":"1","key":"67845_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-023-02379-7","volume":"23","author":"Y An","year":"2023","unstructured":"An, Y. et al. They do not have symptoms\u2013why do they need to take medicines? Challenges in tuberculosis preventive treatment among children in Cambodia: A qualitative study. BMC Pulm. Med. 23(1), 1\u20138 (2023).","journal-title":"BMC Pulm. Med."},{"issue":"11","key":"67845_CR16","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/cid\/ciw126","volume":"62","author":"RN Moro","year":"2016","unstructured":"Moro, R. N. et al. Factors associated with noncompletion of latent tuberculosis infection treatment: Experience from the PREVENT TB trial in the united states and Canada. Clin. Infect. Dis.. 62(11), 1390\u20131400 (2016).","journal-title":"Clin. Infect. Dis.."},{"issue":"4","key":"67845_CR17","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3122\/jabfm.2017.04.170070","volume":"30","author":"MC Eastment","year":"2017","unstructured":"Eastment, M. C., McClintock, A. H., McKinney, C. M., Narita, M. & Molnar, A. Factors that influence treatment completion for latent tuberculosis infection. J. Am. Board Fam. Med. 30(4), 520\u2013527 (2017).","journal-title":"J. Am. Board Fam. Med."},{"key":"67845_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1155\/2014\/349138","volume":"25","author":"K Malejczyk","year":"2014","unstructured":"Malejczyk, K. et al. Factors associated with noncompletion of latent tuberculosis infection treatment in an inner-city population in Edmonton, Alberta. Can. J. Infect. Dis. Med. Microbiol. 25, 281\u2013284 (2014).","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"issue":"4","key":"67845_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.5588\/ijtld.15.0609","volume":"20","author":"A Silva","year":"2016","unstructured":"Silva, A. et al. Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil. Int. J. Tuberc. Lung Dis. 20(4), 479\u2013486 (2016).","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"5","key":"67845_CR20","first-page":"551","volume":"14","author":"A Trajman","year":"2010","unstructured":"Trajman, A. et al. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment. Int. J. Tuberc. Lung Dis. 14(5), 551\u2013559 (2010).","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"3","key":"67845_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5588\/ijtld.22.0571","volume":"27","author":"J Cola","year":"2023","unstructured":"Cola, J. et al. 2023 Factors associated with non-completion of TB preventive treatment in Brazil. Int. J. Tuberc. Lung Dis. 27(3), 215\u2013220 (2023).","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"11","key":"67845_CR22","first-page":"1235","volume":"12","author":"Y Hirsch-Moverman","year":"2008","unstructured":"Hirsch-Moverman, Y., Daftary, A., Franks, J. & Colson, P. Adherence to treatment for latent tuberculosis infection: Systematic review of studies in the US and Canada. Int. J. Tuberc. Lung Dis. 12(11), 1235\u20131254 (2008).","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"12","key":"67845_CR23","doi-asserted-by":"publisher","first-page":"e0001269","DOI":"10.1371\/journal.pgph.0001269","volume":"2","author":"SV Shenoi","year":"2022","unstructured":"Shenoi, S. V. et al. Community-based referral for tuberculosis preventive therapy is effective for treatment completion. PLOS Glob. Public Health 2(12), e0001269 (2022).","journal-title":"PLOS Glob. Public Health"},{"issue":"2","key":"67845_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/cid\/ciad246","volume":"77","author":"L Melnychuk","year":"2023","unstructured":"Melnychuk, L., Perlman-Arrow, S., Lisboa Bastos, M. & Menzies, D. A systematic review and meta-analysis of tuberculous preventative therapy adverse events. Clin. Infect. Dis.. 77(2), 287\u2013294 (2023).","journal-title":"Clin. Infect. Dis.."},{"key":"67845_CR25","unstructured":"National Center for Tuberculosis and Leprosy Control (CENAT). Tuberculosis Report 2022. Phnom Penh, Cambodia; 2022."},{"issue":"12","key":"67845_CR26","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1086\/425610","volume":"39","author":"DH Priest","year":"2004","unstructured":"Priest, D. H., Vossel, L. F. Jr., Sherfy, E. A., Hoy, D. P. & Haley, C. A. Use of intermittent rifampin and pyrazinamide therapy for latent tuberculosis infection in a targeted tuberculin testing program. Clin. Infect. Dis. 39(12), 1764\u20131771 (2004).","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"67845_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1164\/rccm.200303-390OC","volume":"168","author":"PA LoBue","year":"2003","unstructured":"LoBue, P. A. & Moser, K. S. Use of isoniazid for latent tuberculosis infection in a public health clinic. Am. J. Respire. Crit. Care Med. 168(4), 443\u2013447 (2003).","journal-title":"Am. J. Respire. Crit. Care Med."},{"issue":"9","key":"67845_CR28","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(23)00096-6","volume":"11","author":"N Winters","year":"2023","unstructured":"Winters, N. et al. Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: An individual patient data network meta-analysis. Lancet Respir. Med. 11(9), 782\u2013790 (2023).","journal-title":"Lancet Respir. Med."},{"key":"67845_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2245-8","volume":"17","author":"AH McClintock","year":"2017","unstructured":"McClintock, A. H. et al. Treatment completion for latent tuberculosis infection: A retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine. BMC Infect Dis. 17, 1\u20138 (2017).","journal-title":"BMC Infect Dis."},{"issue":"2","key":"67845_CR30","doi-asserted-by":"publisher","first-page":"e0268935","DOI":"10.1371\/journal.pone.0268935","volume":"18","author":"J Musaazi","year":"2023","unstructured":"Musaazi, J. et al. Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda. PloS One 18(2), e0268935 (2023).","journal-title":"PloS One"},{"issue":"7","key":"67845_CR31","doi-asserted-by":"publisher","first-page":"e0001920","DOI":"10.1371\/journal.pgph.0001920","volume":"3","author":"M Sandoval","year":"2023","unstructured":"Sandoval, M. et al. Community-based tuberculosis contact management: Caregiver experience and factors promoting adherence to preventive therapy. PLOS Glob. Public Health 3(7), e0001920 (2023).","journal-title":"PLOS Glob. Public Health"},{"key":"67845_CR32","unstructured":"Organization WH. WHO consolidated guidelines on tuberculosis: module 5: management of tuberculosis in children and adolescents: web annex 3: GRADE evidence to decision tables. 2022."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67845-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67845-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67845-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T10:04:19Z","timestamp":1723197859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67845-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["67845"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-67845-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4442529\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]},"assertion":[{"value":"18 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18458"}}